Abstract
Transcriptional activation of PPARγ by the anti‐diabetic compound troglitazone enhances the rate of 3T3‐L1 adipocyte differentiation. In this study, we examined the effects of troglitazone, a specific PPARγ ligand, on the expression of PPARγ during and after 3T3‐L1 adipocyte differentiation. Troglitazone treatment caused a significant decrease in PPARγ proteins and DNA binding activity. This reduction was associated with a similar decrease in transcription of PPARγ mRNA. These data suggest that in 3T3‐L1 cells, the expression of PPARγ is auto‐regulated.

This publication has 24 references indexed in Scilit: